Balyasny Asset Management’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-15,625
Closed -$1.01M 2002
2018
Q3
$1.01M Buy
+15,625
New +$952K ﹤0.01% 1177
2018
Q2
Sell
-55,765
Closed -$2.62M 2404
2018
Q1
$2.62M Sell
55,765
-473,144
-89% -$22.8M 0.01% 910
2017
Q4
$26.3M Buy
528,909
+484,657
+1,095% +$24.1M 0.08% 326
2017
Q3
$2.56M Sell
44,252
-44,724
-50% -$2.66M 0.01% 894
2017
Q2
$5.97M Buy
88,976
+77,679
+688% +$4.91M 0.02% 705
2017
Q1
$740K Sell
11,297
-29,709
-72% -$1.84M ﹤0.01% 1200
2016
Q4
$2.33M Buy
+41,006
New +$2.37M 0.01% 856
2016
Q3
Sell
-87,378
Closed -$5.71M 1474
2016
Q2
$5.71M Sell
87,378
-35,672
-29% -$2.42M 0.04% 472
2016
Q1
$8.52M Buy
123,050
+113,897
+1,244% +$7.6M 0.05% 437
2015
Q4
$672K Buy
+9,153
New +$651K ﹤0.01% 774

Other funds holding LPNT

Balyasny Asset Management's LPNT Position: Q4 2018 in Review

Balyasny Asset Management sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 15,625 shares — an estimated $1.01M sold.

Balyasny Asset Management first reported a position in LPNT in Q4 2015 and held it in 10 quarters. The position peaked at $26.3M in Q4 2017. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

  • Balyasny Asset Management reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 15,625 LifePoint Health, Inc. shares in Q4 2018, an estimated $1.01M.
  • Balyasny Asset Management first reported a position in LifePoint Health, Inc. in Q4 2015 and held it in 10 quarters.
  • Balyasny Asset Management's LifePoint Health, Inc. position peaked at $26.3M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on Balyasny Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.